Latigo Biotherapeutics Files S-1 With The SEC For Nasdaq Listing
The Form S-1, filed July 17, sets the company's proposed Nasdaq ticker as LTGO.
- Blue Owl Healthcare Opportunities is named among the investor syndicate backing the offering.
- Blue Owl Capital, the fund's manager, itself trades publicly on the NYSE as OWL.
- The filing runs through SEC EDGAR, the federal system logging every public company's disclosures.
Why it matters: Blue Owl Healthcare Opportunities is a fund seeking liquidity, and an IPO is how private capital cashes out.
Latigo Biotherapeutics, Inc. Form S-1 (SEC EDGAR) ↗ · Jul 17, 20267/17/26 · ✓ Checked✓ Check